Whitehawk Therapeutics (WHWK) Total Debt (2020 - 2021)
Whitehawk Therapeutics (WHWK) reported Total Debt of $6.0 million for Q4 2021, down 57.98% year-over-year from $14.3 million in Q4 2020, and up 4.08% quarter-over-quarter from $5.8 million in Q3 2021.
Whitehawk Therapeutics (WHWK) Total Debt (2020 - 2021) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 2 years of Total Debt data on file, last reported at $6.0 million in Q4 2021.
- Total Debt for Q4 2021 came in at $6.0 million, down 57.98% year-over-year; the trailing twelve-month figure through Dec 2021 was $6.0 million (down 57.98% YoY), and the FY2021 annual result was $6.0 million, down 57.98% from the prior year.
- Total Debt rose to $6.0 million in Q4 2021 per WHWK's latest filing, from $5.8 million in the prior quarter.
- Over five years, Total Debt peaked at $14.3 million in Q4 2020 and troughed at $5.8 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 6.02 Mn |
| Sep 30, 2021 | 5.78 Mn |
| Dec 31, 2020 | 14.31 Mn |